Splunk Inc. - SPLK

SPLK Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
SPLK	0	0	0.2	2.8	6.1	72.4	7.4	16.5	159.3	342.2
S&P 500	-0.6	-0.5	1.5	9.1	13.4	32.3	27.0	92.1	191.7	33587.3

Compare SPLK with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	SPLK
name	Splunk Inc.
price	156.9
changes percentage	0.2492
change	0.39
day low	156.9
day high	156.97
year high	156.97
year low	82.19
market cap	26443770355
price avg 50	154.4352
price avg 200	134.2129
exchange	NASDAQ
volume	18211874
avg volume	2010896
open	156.93
previous close	156.51
eps	1.52
pe	103.223684
earnings announcement	2024-05-22T00:00:00.000+0000
shares outstanding	168539008
timestamp	2024-03-15 20:00:01

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 88.7%

Overall Quarterly Financial Health: 56.7%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0001353283
revenue	4215595000	3653708000	15.38
gross profit	3350088000	2837713000	18.06
gross profit ratio	0.79	0.78	2.32
research and development expenses	918834000	997170000	-7.86
operating expenses	2993464000	3073219000	-2.60
interest income	103255000	25401000	306.50
interest expense	42505000	46026000	-7.65
ebitda	445299000	-119955000	471.22
ebitdaratio	0.11	-0.03	421.74
operating income	356624000	-235506000	251.43
operating income ratio	0.08	-0.06	231.25
net income	263733999	-277862000	194.92
net income ratio	0.06	-0.08	182.26
eps	1.58	-1.71	192.40

Overall Score of Annual Income Statement

0.88 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 4,216 million in 2024 from 3,654 million in 2023 representing a change of 15.38%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 3,350 million in 2024 from 2,838 million in 2023 representing a change of 18.06%. This indicates a sales profitability growth, which is a positive sign for the company.

  Operating Expenses: Operating Expenses decreased to 2,993 million in 2024 from 3,073 million in 2023 representing a change of -2.6%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 445 million in 2024 from -120 million in 2023 representing a change of 471.22%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 357 million in 2024 from -236 million in 2023 representing a change of 251.43%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 264 million in 2024 from -278 million in 2023 representing a change of 194.92%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 1.58 in 2024 from 1.58 in 2023 representing a change of 192.4%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 919 million in 2024 from 997 million in 2023 representing a change of -7.86%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q4	2024Q3	Q/Q change %
0001353283
revenue	1486147000	1067355000	39.24
gross profit	1261114000	857382000	47.09
gross profit ratio	0.85	0.8	5.64
research and development expenses	226883000	232541000	-2.43
operating expenses	776027000	774615000	0.18
interest income	23912000	26719000	-10.51
interest expense	9860000	10544000	-6.49
ebitda	504752000	135985000	271.18
ebitdaratio	0.34	0.13	166.58
operating income	485087000	82767000	486.09
operating income ratio	0.33	0.08	320.93
net income	426549000	96853000	340.41
net income ratio	0.29	0.09	216.30
eps	2.52	0.58	334.48

Overall Score of Quarterly Income Statement

0.5 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 1,486 million in 2024Q4 from 1,067 million in 2024Q3 representing a change of 39.24%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 1,261 million in 2024Q4 from 857 million in 2024Q3 representing a change of 47.09%. This indicates a sales profitability growth, which is a positive sign for the company.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 505 million in 2024Q4 from 136 million in 2024Q3 representing a change of 271.18%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Earnings per Share (EPS): EPS increased to 2.52 in 2024Q4 from 2.52 in 2024Q3 representing a change of 334.48%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 227 million in 2024Q4 from 233 million in 2024Q3 representing a change of -2.43%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Operating Expenses: Operating Expenses increased to 776 million in 2024Q4 from 775 million in 2024Q3 representing a change of 0.18%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  Operating Income: Operating income decreased to 485 million in 2024Q4 from 83 million in 2024Q3 representing a change of 486.09%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to 427 million in 2024Q4 from 97 million in 2024Q3 representing a change of 340.41%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0001353283
total assets	6687356000	6343923000	5.41
total liabilities	5946747000	6454436000	-7.87
total equity	740609000	-110513000	770.16
cash and cash equivalents	1643141000	690587000	137.93
short term investments	360412000	1316347000	-72.62
long term investments	530841000	41700000	1173.00
total current assets	4006953000	3870684000	3.52
total non current assets	2680403000	2445252000	9.62
total current liabilities	2557894000	3035670000	-15.74
total non current liabilities	3388853000	3418766000	-0.87
common stock	177000	171000	3.51
retained earnings	-3523001000	-3786735000	6.96
total debt	3261572000	4077213000	-20.00

Overall Score of Annual Balance Sheet

0.9 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 6,687 million in 2024 from 6,344 million in 2023 representing a change of 5.41%. Suggesting a growth in asset holdings.

  Total Liabilities: Total Liabilities decreased to 5,947 million in 2024 from 6,454 million in 2023 representing a change of -7.87%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 741 million in 2024 from -111 million in 2023 representing a change of 770.16%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 1,643 million in 2024 from 691 million in 2023 representing a change of 137.93%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 4,007 million in 2024 from 3,871 million in 2023 representing a change of 3.52%. This indicates a better liquidity position.

  Total Current Liabilities: Total Current Liabilities decreased to 2,558 million in 2024 from 3,036 million in 2023 representing a change of -15.74%. This indicates a lower short-term debt burden.

  Common Stock: Common Stock increased to 0 in 2024 from 0 in 2023 representing a change of 3.51%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to -3,523 million in 2024 from -3,787 million in 2023 representing a change of 6.96%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 3,262 million in 2024 from 4,077 million in 2023 representing a change of -20.0%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Short Term Investments: Short Term Investments decreased to 360 million in 2024 from 1,316 million in 2023 representing a change of -72.62%. This indicates a decrease in short-term investment holdings.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q4	2024Q3	Q/Q change %
0001353283
total assets	6687356000	5391780000	24.03
total liabilities	5946747000	5192895000	14.52
total equity	740609000	198885000	272.38
cash and cash equivalents	1643141000	927962000	77.07
short term investments	360412000	761746000	-52.69
long term investments	530841000	41630000	1175.14
total current assets	4006953000	3080857000	30.06
total non current assets	2680403000	2310923000	15.99
total current liabilities	2557894000	1821540000	40.42
total non current liabilities	3388853000	3371355000	0.52
common stock	177000	175000	1.14
retained earnings	-3523001000	-3949550000	10.80
total debt	3261572000	3261761000	-0.01

Overall Score of Quarterly Balance Sheet

0.7 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 6,687 million in 2024Q4 from 5,392 million in 2024Q3 representing a change of 24.03%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 741 million in 2024Q4 from 199 million in 2024Q3 representing a change of 272.38%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 1,643 million in 2024Q4 from 928 million in 2024Q3 representing a change of 77.07%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 4,007 million in 2024Q4 from 3,081 million in 2024Q3 representing a change of 30.06%. This indicates a better liquidity position.

  Common Stock: Common Stock increased to 0 in 2024Q4 from 0 in 2024Q3 representing a change of 1.14%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to -3,523 million in 2024Q4 from -3,950 million in 2024Q3 representing a change of 10.8%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 3,262 million in 2024Q4 from 3,262 million in 2024Q3 representing a change of -0.01%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 5,947 million in 2024Q4 from 5,193 million in 2024Q3 representing a change of 14.52%. This indicates an increase in overall liabilities.

  Short Term Investments: Short Term Investments decreased to 360 million in 2024Q4 from 762 million in 2024Q3 representing a change of -52.69%. This indicates a decrease in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities increased to 2,558 million in 2024Q4 from 1,822 million in 2024Q3 representing a change of 40.42%. This indicates a higher short-term debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0001353283
net change in cash	952554000	-738104000	229.05
operating cash flow	1008363000	449630000	124.27
free cash flow	985646000	427228000	130.71
capital expenditure	-22717000	-22402000	-1.41
depreciation and amortization	88675000	99470000	-10.85
deferred income tax	2079000	-2695000	177.14
stock based compensation	786824000	789138000	-0.29
accounts payables	19416000	-43907000	144.22
inventory	0	0	NaN
acquisitions net	502000	-21950000	102.29
investments in property plant and equipment	-22717000	-22402000	-1.41
net cash used for investing activites	935668000	-1070160000	187.43
debt repayment	0	0	NaN
common stock issued	82258000	1457000	5545.71
common stock repurchased	0	-197349000	100.00
dividends paid	0	0	NaN
net cash used provided by financing activities	-989026000	-117574000	-741.19
cash at end of period	1643141000	690587000	137.93
accounts receivables	-447212000	-337177000	-32.63
cash at beginning of period	690587000	1428691000	-51.66

Overall Score of Annual Cashflow Statement

0.88 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 953 million in 2024 from -738 million in 2023 representing a change of 229.05%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 1,008 million in 2024 from 450 million in 2023 representing a change of 124.27%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 986 million in 2024 from 427 million in 2023 representing a change of 130.71%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -23 million in 2024 from -22 million in 2023 representing a change of -1.41%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Stock-Based Compensation: Stock-Based Compensation decreased to 787 million in 2024 from 789 million in 2023 representing a change of -0.29%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables decreased to 19 million in 2024 from 44 million in 2023 representing a change of 144.22%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables decreased to -447 million in 2024 from -337 million in 2023 representing a change of -32.63%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• 📉 Negative Indicators

  Deferred Income Tax: Deferred Income Tax increased to 2 million in 2024 from -3 million in 2023 representing a change of 177.14%. This indicates that the company's tax liability for future periods has increased.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q4	2024Q3	Q/Q change %
0001353283
operating cash flow	421347000	85385000	393.47
free cash flow	416777000	78263000	432.53
capital expenditure	-4570000	-7122000	35.83
depreciation and amortization	19665000	22065000	-10.88
deferred income tax	2572000	16000	15975.00
stock based compensation	209360000	193947000	7.95
accounts receivables	-959065000	-188924000	-407.65
accounts payables	29488000	-20987000	240.51
inventory	0	22253000	-100.00
acquisitions net	502000	3809000	-86.82
investments in property plant and equipment	-4570000	-7122000	35.83
net cash used for investing activites	392389000	151727000	158.62
debt repayment	0	0	NaN
common stock issued	30644000	183000	16645.36
common stock repurchased	0	0	NaN
dividends paid	0	0	NaN
net cash used provided by financing activities	-96106000	-832612000	88.46
net change in cash	715179000	-595500000	220.10
cash at end of period	1643141000	927962000	77.07
cash at beginning of period	927962000	1523462000	-39.09

Overall Score of Quarterly Cashflow Statement

0.5 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 715 million in 2024Q4 from -596 million in 2024Q3 representing a change of 220.1%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 421 million in 2024Q4 from 85 million in 2024Q3 representing a change of 393.47%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 417 million in 2024Q4 from 78 million in 2024Q3 representing a change of 432.53%. This indicates an increase in cash generated after accounting for capital expenditures.

  Accounts Receivables: Accounts Receivables decreased to -959 million in 2024Q4 from -189 million in 2024Q3 representing a change of -407.65%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• 📉 Negative Indicators

  Capital Expenditure: Capital Expenditure increased to -5 million in 2024Q4 from -7 million in 2024Q3 representing a change of 35.83%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Deferred Income Tax: Deferred Income Tax increased to 3 million in 2024Q4 from 0 million in 2024Q3 representing a change of 15975.0%. This indicates that the company's tax liability for future periods has increased.

  Stock-Based Compensation: Stock-Based Compensation increased to 209 million in 2024Q4 from 194 million in 2024Q3 representing a change of 7.95%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables increased to 29 million in 2024Q4 from 21 million in 2024Q3 representing a change of 240.51%. This indicates that the company has increased its outstanding obligations to its suppliers.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q2 2024 Earnings call transcript
Q1 2024 Earnings call transcript
Q4 2023 Earnings call transcript
Q3 2023 Earnings call transcript
Q2 2023 Earnings call transcript
Q1 2023 Earnings call transcript
Q4 2022 Earnings call transcript
Q3 2022 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2024-01-31	2023-01-31	Y/Y change %
FY
calendar year	2024	2023	NaN
revenue per share	25.22	22.5	12.09
net income per share	1.58	-1.71	192.21
operating cash flow per share	6.03	2.77	117.88
free cash flow per share	5.9	2.63	124.14
cash per share	11.99	12.36	-3.01
book value per share	4.43	-0.68	751.07
tangible book value per share	-4.05	-10.14	60.11
shareholders equity per share	4.43	-0.68	751.07
interest debt per share	18.84	25.39	-25.79
market cap	25633648320	15550749520	64.84
enterprise value	27252079320	18937375520	43.91
pe ratio	97.2	-55.97	273.67
price to sales ratio	6.08	4.26	42.87
pocfratio	25.42	34.59	-26.50
pfcf ratio	26.01	36.4	-28.55
pb ratio	34.61	-140.71	124.60
ptb ratio	34.61	-140.71	124.60
ev to sales	6.46	5.18	24.73
enterprise value over ebitda	61.2	-157.87	138.77
ev to operating cash flow	27.03	42.12	-35.83
ev to free cash flow	27.65	44.33	-37.62
earnings yield	0.01	-0.02	157.58
free cash flow yield	0.04	0.03	39.96
debt to equity	4.2	-36.89	111.37
debt to assets	0.46	0.64	-27.71
net debt to ebitda	3.63	-28.23	112.87
current ratio	1.57	1.28	22.86
interest coverage	8.39	-5.12	263.97
income quality	3.82	-1.62	336.28
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0.12	0.12	-3.06
research and ddevelopement to revenue	0.22	0.27	-20.14
intangibles to total assets	0.21	0.24	-12.52
capex to operating cash flow	0.02	0.05	-54.78
capex to revenue	0.01	0.01	-12.11
capex to depreciation	0.26	0.23	13.75
stock based compensation to revenue	0.19	0.22	-13.58
graham number	12.54	5.12	145.02
roic	0.08	-0.06	232.36
return on tangible assets	0.05	-0.06	186.58
graham net net	-15.33	-20.08	23.66
working capital	1449059000	835014000	73.54
tangible asset value	-676311000	-1647021000	58.94
net current asset value	-1939794000	-2583752000	24.92
invested capital	3082274000	2667043000	15.57
average receivables	1720759500	1453628500	18.38
average payables	25007000	37252500	-32.87
average inventory	-13993500	-13993500	0.00
days sales outstanding	159.39	159.9	-0.31
days payables outstanding	14.64	6.84	113.93
days of inventory on hand	0	-12.52	100.00
receivables turnover	2.29	2.28	0.32
payables turnover	24.93	53.34	-53.26
inventory turnover	0	-29.16	100.00
roe	0.36	2.51	-85.84
capex per share	0.14	0.14	-1.48

• Neutral

  ROE: Return on Equity (ROE) decreased to 0.36 on 2024-01-31 from 2.51 on 2023-01-31, representing a change of -85.84%. However, ROE is >= 15%, suggesting that the company has been generating high returns for its shareholders still.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 97.20 on 2024-01-31 from -55.97 on 2023-01-31, representing a change of 273.67%. Indicating an increase in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 1.57 on 2024-01-31 from 1.28 on 2023-01-31, representing a change of 22.86%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

• Negative

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 4.20 on 2024-01-31 from -36.89 on 2023-01-31, representing a change of 111.37%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. A ratio of 2.0 or higher is usually considered risky.

• Quarterly Financial Ratios

	2024-01-31 Q4	2023-10-31 Q3	Q/Q change %
SPLK
calendar year	2024	2024	NaN
revenue per share	8.79	5.74	53.14
net income per share	2.52	0.52	384.40
operating cash flow per share	2.49	0.46	442.76
free cash flow per share	2.46	0.42	485.73
cash per share	11.85	9.09	30.42
book value per share	4.38	1.07	309.58
tangible book value per share	-4.4	-7.32	39.97
shareholders equity per share	4.38	1.07	309.58
interest debt per share	18.43	17.59	4.76
market cap	25933640040	27369111120	-5.24
enterprise value	27552071040	29702910120	-7.24
pe ratio	15.2	70.65	-78.48
price to sales ratio	17.45	25.64	-31.95
pocfratio	61.55	320.54	-80.80
pfcf ratio	62.22	349.71	-82.21
pb ratio	35.02	137.61	-74.55
ptb ratio	35.02	137.61	-74.55
ev to sales	18.54	27.83	-33.38
enterprise value over ebitda	54.59	218.43	-75.01
ev to operating cash flow	65.39	347.87	-81.20
ev to free cash flow	66.11	379.53	-82.58
earnings yield	0.02	0.0	364.79
free cash flow yield	0.02	0.0	462.01
debt to equity	4.2	16.4	-74.42
debt to assets	0.46	0.6	-23.20
net debt to ebitda	3.21	17.16	-81.32
current ratio	1.57	1.69	-7.38
interest coverage	49.2	7.85	526.75
income quality	0.99	0.88	12.05
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0.11	0.13	-19.07
research and ddevelopement to revenue	0.15	0.22	-29.93
intangibles to total assets	0.22	0.29	-23.34
capex to operating cash flow	0.01	0.08	-87.00
capex to revenue	0.0	0.01	-53.91
capex to depreciation	0.23	0.32	-28.00
stock based compensation to revenue	0.14	0.18	-22.47
graham number	15.77	3.54	345.42
roic	0.12	0.02	442.76
return on tangible assets	0.08	0.03	224.26
graham net net	-15.15	-14.27	-6.18
working capital	1449059000	1259317000	15.07
tangible asset value	-743274000	-1361779000	45.42
net current asset value	-1939794000	-2112038000	8.16
invested capital	3149237000	2999873000	4.98
average receivables	1486272000	1052909000	41.16
average payables	19971000	15720500	27.04
average inventory	0.5	0.5	0.00
days sales outstanding	111.49	95.42	16.84
days payables outstanding	13.88	2.24	519.70
days of inventory on hand	0	0.0	-100.00
receivables turnover	0.81	0.94	-14.41
payables turnover	6.48	40.17	-83.86
inventory turnover	0	209973000	-100.00
roe	0.58	0.49	18.27
capex per share	0.03	0.04	-29.42

• Positive

  ROE: Return on Equity (ROE) increased to 0.58 on 2024-01-31 Q4 from 0.49 on 2023-10-31 Q3, representing a change of 18.27%. Suggesting the company has been generating high returns for its shareholders.

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 15.20 on 2024-01-31 Q4 from 70.65 on 2023-10-31 Q3, representing a change of -78.48%. Indicating a decrease in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 4.20 on 2024-01-31 Q4 from 16.40 on 2023-10-31 Q3, representing a change of -74.42%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. However, a ratio of 2.0 or higher is usually considered risky.

• Neutral

  Current Ratio: Current Ratio decreased to 1.57 on 2024-01-31 Q4 from 1.69 on 2023-10-31 Q3, representing a change of -7.38%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Negative Sentiment: Discounted Cash Flow value is 7.18 which is lower than current price 156.9, indicates the company may be overvalued.